Each instance of prostate cancer is exceptional --necessitating an individualized strategy --and the bewildering array of treatments available can confound the patient and his loved ones grappling with how best to navigate through the powerful process of diagnosis and management. The advantages and disadvantages of each control option are assessed in as impartial a means as you possibly can so as to empower the patient to become a player in his curative journey and enable him to select the treatment that is most suitable for him.
PROSTATE CANCER 20/20 reviews the unprecedented number of improvements in addressing prostate cancer that have happened throughout the last few years. These include improvements in screening and diagnostic testing, progressively complex imaging techniques, the development and refinement of genetic testing, the access to numerous new medications, continued technical improvements in chemotherapy, surgical and focal therapies as well as the blossoming of the era of""active surveillance""
Since many patients with prostate cancer have an superb prognosis, the long-term consequences of the disease are the side effects of treatment. PROSTATE CANCER 20/20 provides detailed information on the most common complications after therapy --sexual dysfunction and urinary incontinence--conditions that can be successfully managed through an assortment of means comprehensive within the publication.
Related Subjects
Law